DJIA 16,461.32 -153.49 -0.92%
NASDAQ 4,382.85 -36.63 -0.83%
S&P 500 1,927.11 -14.17 -0.73%
market minute promo

Verastem, Inc. (NASDAQ: VSTM)

8.99 0.01 (0.11%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VSTM $8.99 0.11%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.05
Previous Close $8.98
Daily Range $8.81 - $9.15
52-Week Range $7.10 - $16.60
Market Cap $232.3M
P/E Ratio -4.73
Dividend (Yield) $0.00 (0.0%)
Volume 104,888
Average Daily Volume 196,733
Current FY EPS -$2.03

Sector

Healthcare

Industry

Drugs

Verastem, Inc. (VSTM) Description

Verastem Inc is a biopharmaceutical company focused on discovering and developing proprietary small molecule drugs targeting cancer stem cells along with proprietary companion diagnostics. Website: http://www.verastem.com/

News & Commentary Rss Feed

Verastem Inc.'s Upcoming Catalysts

Verastem might have to compete with GlaxoSmithKine, but Eli Lilly won't be a problem since it's targeting patients that have already taken Lilly's drug.

Verastem (VSTM) Crumbles: Stock Falls by 6.1% - Tale of the Tape

Verastem (VSTM) in Focus: Stock Adds 14% in Session - Tale of the Tape

Why Verastem Inc Shares Took Off Today

Is this meaningful? Or just another movement?

Healthcare Stocks Mixed; Verastem Surges After Publishing Supportive Data for Its Anti-Cancer Therap

Healthcare Stocks Mixed; Verastem Surges After Publishing Supportive Data for Its Anti-Cancer Therapy

Sector Update: Healthcare

UPDATE: Deutsche Bank Initiates Coverage On Verastem On Multiple Positive Factors

Oversold Conditions For Verastem (VSTM)

Verastem: Cancer May Have Met Its Match

Verastem Becomes Oversold (VSTM)

See More VSTM News...